← Back to headlines

China's AI Advances in Cancer Screening and Rare Disease Diagnosis
Chinese companies are making significant strides in personalized medicine, utilizing AI to boost cancer screening and rare disease diagnosis, with firms like MGI Tech and BGI Genomics leading in gene sequencing.
2 Mar, 05:00 — 2 Mar, 05:00
ℹOnly 1 source covers this story


